News & Updates

Show Multimedia Only
Cyclosporin may increase malignancy risk in psoriasis

Cyclosporin may increase malignancy risk in psoriasis

07 Dec 2022

In psoriasis patients, treatment with cyclosporin may increase the risk of malignancy without nonmelanoma skin cancer, a recent study has found. Biologic or phototherapy have no such impact.

Cyclosporin may increase malignancy risk in psoriasis

07 Dec 2022
Erenumab works well in chronic migraine patients across Asia

Erenumab works well in chronic migraine patients across Asia

06 Dec 2022 byJairia Dela Cruz

Erenumab proves to be effective at lowering the number of monthly migraine days in Asian patients with chronic migraine while having a favourable safety profile, according to the results of DRAGON study.

Erenumab works well in chronic migraine patients across Asia

06 Dec 2022